Two medications have proven to be most effective in keeping blood glucose levels within a target range while managing type 2 diabetes, a disease that affects more than 32 million Americans. Out of four medications commonly ...
Jul 2, 2021
1
3
(HealthDay)—Type 2 diabetes can be tough to control without medication. But for some people, the thought of daily shots makes them delay or avoid starting insulin therapy.
Sep 22, 2020
0
25
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, ...
Mar 1, 2016
0
16
Mounjaro (tirzepatide) injection was approved as an addition to diet and exercise to improve blood glucose control in adults with type 2 diabetes, the U.S. Food and Drug Administration announced May 13.
May 21, 2022
0
8
In a large clinical trial that directly compared four drugs commonly used to treat type 2 diabetes, researchers found that insulin glargine and liraglutide performed the best of four medications approved by the U.S. Food ...
Sep 21, 2022
0
41
(HealthDay)—Type 2 diabetes can be misdiagnosed in patients with hemoglobin (Hb) Wayne, according to a case report published online Aug. 20 in Diabetes Care.
Aug 26, 2015
0
11
(HealthDay)—For patients with type 2 diabetes, basal insulin peglispro (BIL) provides better glycemic control than insulin glargine, with increased triglycerides, aminotransferases, and liver fat content, according to a ...
Nov 30, 2015
0
2
(HealthDay)—For patients with type 2 diabetes, exenatide twice daily added to insulin glargine is efficacious across body mass index (BMI) ranges, according to a study published online March 29 in Diabetes, Obesity and ...
Apr 11, 2016
0
0
An exploratory analysis of data from the SURPASS-4 trial has shown that adults with type 2 diabetes and increased cardiovascular risk receiving tirzepatide experience fewer renal complications, especially new onset of macroalbuminuria; ...
Jun 6, 2022
0
7
(HealthDay)—The addition of subcutaneous tirzepatide versus placebo to titrated insulin glargine results in significant improvements in glycemic control among patients with type 2 diabetes and inadequate glycemic control, ...
Feb 10, 2022
0
2
